小于胎龄儿子亚组在2岁时呈现不同的发病率、生长和神经发育结局:INTERBIO-21st新生儿研究
前瞻性队列研究纳入6国5153名非小于胎龄儿和1549名小于胎龄儿,识别出9个小于胎龄儿亚组,各亚组新生儿发病率、生长和2岁时神经发育结局不同。
要点
- 小于胎龄儿可分为9个基于母亲、胎儿和环境因素的亚组
- 重度小于胎龄儿中『严重母亲疾病』『既往低出生体重或早产』『吸烟』亚组发病和生长风险增高
- 中度小于胎龄儿中『高血压疾病』亚组新生儿发病和语言、积极行为得分低于常模第10百分位风险增高
核心结论
- 小于胎龄儿包含异质性亚组,各亚组在新生儿发病率、生后生长和至2岁神经发育结局上呈现不同模式。
研究设计与样本
- 前瞻性队列研究,2012年至2018年在全球6个国家纳入INTERBIO-21st研究的非小于胎龄儿5153名和小于胎龄儿1549名(中度≥第3-<第10百分位947名,重度<第3百分位602名),随访至2岁。
- 采用两步聚类分析识别小于胎龄儿亚组,基于拟合统计量以概率方法选择最优亚组模型。
- 采用logistic回归分析(比值比;95%置信区间)评估亚组健康与发育结局,以非小于胎龄儿为参照组并调整关键混杂因素。
主要发现
- 识别出9个小于胎龄儿亚组:『未检测到主要情况』29.0%、『既往低出生体重或早产』14.6%、『严重母亲疾病』12.0%、『母亲身材矮小』11.6%、『高血压疾病』9.6%、『宫外感染』6.8%、『既往流产』6.5%、『吸烟』5.2%、『母亲营养不良』4.7%。
- 重度小于胎龄儿中『严重母亲疾病』亚组(比值比3.2;95%置信区间1.8-6.0)、『既往低出生体重或早产』亚组(比值比2.8;95%置信区间1.6-4.8)、『吸烟』亚组(比值比5.4;95%置信区间1.3-21.8)较非小于胎龄儿组新生儿和长期发病率及2岁时人体测量指标低下风险增高。
- 中度小于胎龄儿中『高血压疾病』亚组较非小于胎龄儿组新生儿发病率风险增高(比值比2.6;95%置信区间1.5-4.6),语言(比值比3.5;95%置信区间1.0-12.0)和积极行为(比值比2.2;95%置信区间1.1-4.5)得分低于常模第10百分位的比值增高。
- 『严重母亲疾病』亚组语言(比值比5.7;95%置信区间1.3-24.8)和积极行为(比值比3.4;95%置信区间1.5-7.6)得分低于常模第10百分位的风险增高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Small for gestational age is a complex perinatal syndrome associated with increased neonatal morbidity, mortality, and impaired childhood growth and neurodevelopment. Current classifications rely primarily on birthweight, which does not capture the heterogeneity of the condition nor predict long-term health outcomes. Here we aim to identify and characterize distinct small for gestational age subgroups and assess their neonatal and early childhood health trajectories. OBJECTIVE: To refine the classification of small for gestational age by identifying subgroups based on maternal, fetal, and environmental factors and evaluating their associations with neonatal morbidity, growth, and neurodevelopment at age 2. STUDY DESIGN: Prospective cohort study. In six countries worldwide, between 2012 and 2018, the INTERBIO-21st Study enrolled small for gestational age and non-small for gestational age newborns defined by the <10th centile of international standards with moderate (≥third-<10th centile) and severe (<third centile) small for gestational age subgroups; we assessed their growth, health, nutrition, motor development, and neurodevelopment up to age 2. We used 2-step cluster analysis to identify small for gestational age subgroups, and a probabilistic approach to choose the optimal subgroup model based on a statistical measure of fit. We performed logistic regression analysis (odds ratio; 95% confidence interval) to assess health and development outcomes among subgroups using the non-small for gestational age as reference group, adjusting for key confounders. RESULTS: We enrolled 5153 non-small for gestational age and 1549 small for gestational age newborns: moderate (≥third-<10th centile) small for gestational age=947 and severe (<third centile) small for gestational age=602. We identified 9 small for gestational age subgroups: "no main condition detected" (29.0%); "previous low birthweight or preterm birth" (14.6%); "severe maternal disease" (12.0%); "maternal short stature" (11.6%); "hypertensive disorders" (9.6%); "extrauterine infection" (6.8%); "previous miscarriage(s)" (6.5%); "smoking" (5.2%); and "maternal undernutrition" (4.7%). Severe small for gestational age newborns in the "severe maternal disease" (odds ratio, 3.2; 95% confidence interval, 1.8-6.0), "previous low birthweight or preterm birth" (odds ratio, 2.8; 95% confidence interval, 1.6-4.8), and "smoking" (odds ratio, 5.4; 95% confidence interval, 1.3-21.8) subgroups had increased risk of neonatal and long-term morbidity and low anthropometric measures at age 2 as compared to the non-small for gestational age group. Moderate small for gestational age newborns in the "hypertensive disorders" subgroup had increased risk of neonatal morbidity (odds ratio, 2.6; 95% confidence interval, 1.5-4.6) and higher odds of scoring <10th centile of normative values in language (odds ratio, 3.5; 95% confidence interval, 1.0-12.0) and positive behavior (odds ratio, 2.2; 95% confidence interval, 1.1-4.5). The "severe maternal disease" subgroup had also higher risk of deficit (<10th centile of normative values) in language (odds ratio, 5.7; 95% confidence interval, 1.3-24.8) and positive behavior (odds ratio, 3.4; 95% confidence interval, 1.5-7.6). CONCLUSION: Small for gestational age comprises heterogeneous subgroups with distinct patterns of neonatal morbidity, postnatal growth, and neurodevelopmental outcomes up to age 2.
引用
- Papageorghiou AT, Restrepo-Méndez MC, McGready R, et al. Small for gestational age subgroups have differential morbidity, growth, and neurodevelopment at age 2: the INTERBIO-21st Newborn Study. Am J Obstet Gynecol. 2025. PMID: 40414409. doi:10.1016/j.ajog.2025.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。